1. Home
  2. ASMB vs BTQ Comparison

ASMB vs BTQ Comparison

Compare ASMB & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$29.44

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

BTQ

BTQ Technologies Corp.

N/A

Current Price

$2.99

Market Cap

448.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
BTQ
Founded
2005
1983
Country
United States
Canada
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.0M
448.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
BTQ
Price
$29.44
$2.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$44.20
$10.00
AVG Volume (30 Days)
70.0K
1.8M
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2,332.99
Revenue Next Year
$235.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.68
$2.09
52 Week High
$39.71
$16.00

Technical Indicators

Market Signals
Indicator
ASMB
BTQ
Relative Strength Index (RSI) 53.25 58.46
Support Level $29.31 $2.23
Resistance Level $30.54 $3.37
Average True Range (ATR) 1.44 0.24
MACD 0.10 0.08
Stochastic Oscillator 68.18 86.83

Price Performance

Historical Comparison
ASMB
BTQ

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About BTQ BTQ Technologies Corp.

BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. Its products include PQScale, Keelung, Kenting, and Qbyte. PQScale is a novel scaling technique for post-quantum cryptographic primitives. Keelung is a zero-knowledge toolkit for fast, private, and secure applications. Kenting provides acceleration for NIST-compliant post-quantum cryptography, post-quantum zk-SNARKs, and eco-friendly mining hardware, and Qbyte is a quantum risk calculator. Geographically, the company derives maximum revenue from Canada, and also has a presence in Taiwan, and Australia.

Share on Social Networks: